Goldman Sachs upgraded Covidien (NYSE: COV) from Neutral to Buy with a price target of $73.00 (from $72.00). Analyst David ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE